Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Alvaro Santos‐Laso"'
Autor:
María Gutiérrez-Larrañaga, Elena González-López, Adriel Roa-Bautista, Pedro M. Rodrigues, Álvaro Díaz-González, Jesus M. Banales, Marcos López-Hoyos, Alvaro Santos-Laso, Javier Crespo
Publikováno v:
Liver Cancer, Pp 1-16 (2021)
Background: Cholangiocarcinoma (CCA) encompasses a heterogeneous group of malignant tumors with dismal prognosis and increasing incidence worldwide. Both late diagnosis due to the lack of early symptoms and the refractory nature of these tumors serio
Externí odkaz:
https://doaj.org/article/2b37b2a9b2e24e5d9bf967a229fdd4b0
Autor:
Paula Iruzubieta, Tatiana Fernández-Lanas, Laura Rasines, Lorena Cayon, Ana Álvarez-Cancelo, Alvaro Santos-Laso, Agustín García-Blanco, Soraya Curiel-Olmo, Joaquín Cabezas, Reinhard Wallmann, Emilio Fábrega, Víctor M. Martínez-Taboada, José L. Hernández, Marcos López-Hoyos, Jeffrey V. Lazarus, Javier Crespo
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract The simplicity and low cost of rapid point-of-care tests greatly facilitate large-scale population testing, which can contribute to controlling the spread of the COVID-19 virus. We evaluated the applicability of a self-testing strategy for S
Externí odkaz:
https://doaj.org/article/7b9e4027475d423480ce024e071262c0
Autor:
Monika Lewinska, PhD, Alvaro Santos-Laso, PhD, Enara Arretxe, PhD, Cristina Alonso, PhD, Ekaterina Zhuravleva, PhD, Raul Jimenez-Agüero, MD, PhD, Emma Eizaguirre, MD, PhD, María Jesús Pareja, MD, PhD, Manuel Romero-Gómez, MD, PhD, Marco Arrese Jimenez, MD, PhD, Malte P. Suppli, MD, PhD, Filip K. Knop, MD, PhD, Stine Karlsen Oversoe, MD, PhD, Gerda Elisabeth Villadsen, MD, PhD, Thomas Decaens, MD, PhD, Flair Jose Carrilho, MD, PhD, Claudia PMS de Oliveira, MD, PhD, Bruno Sangro, MD, PhD, Rocio I.R. Macias, MD, PhD, Jesus M. Banales, PhD, Jesper B. Andersen, PhD
Publikováno v:
EBioMedicine, Vol 73, Iss , Pp 103661- (2021)
Background: Non-alcoholic fatty liver disease (NAFLD) is affecting more people globally. Indeed, NAFLD is a spectrum of metabolic dysfunctions that can progress to hepatocellular carcinoma (NAFLD-HCC). This development can occur in a non-cirrhotic li
Externí odkaz:
https://doaj.org/article/a98663c5714b4b39a2da1a493b1539b3
Autor:
Jeffrey V. Lazarus, Marcela Villota-Rivas, Carolina Jiménez-González, Alvaro Santos-Laso, Paula Iruzubieta, María Teresa Arias-Loste, Lisa Rice-Duek, Simon Leigh, Christopher J. Kopka, Juan Turnes, José Luis Calleja, Javier Crespo
Publikováno v:
Clinics in Liver Disease. 27:515-533
Autor:
Alvaro Santos-Laso, María Gutiérrez-Larrañaga, Marta Alonso-Peña, Juan M. Medina, Paula Iruzubieta, María Teresa Arias-Loste, Marcos López-Hoyos, Javier Crespo
Publikováno v:
Biomedicines, Vol 10, Iss 1, p 46 (2021)
Non-alcoholic fatty liver disease (NAFLD) is characterized by the excessive and detrimental accumulation of liver fat as a result of high-caloric intake and/or cellular and molecular abnormalities. The prevalence of this pathological event is increas
Externí odkaz:
https://doaj.org/article/165eb0fb2aee416da24d72bb7af95b1f
Autor:
Ainhoa Lapitz, Ander Arbelaiz, Colm J. O’Rourke, Jose L. Lavin, Adelaida La Casta, Cesar Ibarra, Juan P. Jimeno, Alvaro Santos-Laso, Laura Izquierdo-Sanchez, Marcin Krawczyk, Maria J. Perugorria, Raul Jimenez-Aguero, Alberto Sanchez-Campos, Ioana Riaño, Esperanza Gónzalez, Frank Lammert, Marco Marzioni, Rocio I.R. Macias, Jose J. G. Marin, Tom H. Karlsen, Luis Bujanda, Juan M. Falcón-Pérez, Jesper B. Andersen, Ana M. Aransay, Pedro M. Rodrigues, Jesus M. Banales
Publikováno v:
Cells, Vol 9, Iss 3, p 721 (2020)
Cholangiocarcinoma (CCA) comprises a group of heterogeneous biliary cancers with dismal prognosis. The etiologies of most CCAs are unknown, but primary sclerosing cholangitis (PSC) is a risk factor. Non-invasive diagnosis of CCA is challenging and ac
Externí odkaz:
https://doaj.org/article/3b3b763b3a064cf0b5e939942071ce9a
Autor:
Julen Oyarzabal, Robert Arnes-Benito, Leticia Colyn, Jose J.G. Marin, Jose M Herranz, Maite G. Fernandez-Barrena, María J. Iraburu, Maria Francesconi, Gloria Alvarez-Sola, Meritxell Huch, Leonard J Nelson, Francisco Javier Cubero, Matías A. Avila, Altaf A. Dar, Jesus M. Banales, Iker Uriarte, Mikel Ruiz de Gauna, Simone Carotti, Jesús Urman, Sergio Morini, María L. Martínez-Chantar, Chaobo Chen, Marina Bárcena-Varela, Eva Santamaría, Andrea Casadei-Gardini, Christian Trautwein, Patricia Aspichueta, Alvaro Santos-Laso, Carmen Berasain, Felipe Prosper, Bruno Sangro, John M Patino, Matteo Canale, Mehdi Nosrati, María Arechederra, M. Ujue Latasa
Publikováno v:
Hepatology. 73:2380-2396
Background and aims Cholangiocarcinoma (CCA) is a devastating disease often detected at advanced stages when surgery cannot be performed. Conventional and targeted systemic therapies perform poorly, and therefore effective drugs are urgently needed.
Autor:
Jorge Adeva, Alvaro Santos-Laso, Vincenzo Cardinale, Marcin Krawczyk, Simone Stock, Alejandro Forner, Rocio I.R. Macias, Marek Krawczyk, Juan W. Valle, Adelaida La Casta, Domenico Alvaro, Chiara Braconi, Luca Fabris, Matthias Evert, Angela Lamarca, Trine Folseraas, Jesus M. Banales, Kirsten Utpatel
Publikováno v:
Hepatology (Baltimore, Md.)
Addi. Archivo Digital para la Docencia y la Investigación
instname
Addi: Archivo Digital para la Docencia y la Investigación
Universidad del País Vasco
Addi. Archivo Digital para la Docencia y la Investigación
instname
Addi: Archivo Digital para la Docencia y la Investigación
Universidad del País Vasco
[EN] BACKGROUND AND AIMS: Intrahepatic cholangiocarcinoma (iCCA) with liver metastases is perceived to have a poor prognosis, but the American Joint Committee on Cancer (AJCC) classifies them as early stage in the absence of lymph nodes or extrahepat
Autor:
Javier Crespo, Lorena Cayon, Ana Álvarez-Cancelo, Víctor M. Martínez-Taboada, Emilio Fábrega, Tatiana Fernández-Lanas, Alvaro Santos-Laso, Paula Iruzubieta, Reinhard Wallmann, Jeffrey V. Lazarus, Joaquín Cabezas, Soraya Curiel-Olmo, Laura Rasines, Marcos López-Hoyos, José L. Hernández, Agustín García-Blanco
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Scientific Reports
Sci Rep . 2021 May 10;11(1):9819
UCrea Repositorio Abierto de la Universidad de Cantabria
Universidad de Cantabria (UC)
Scientific Reports
Sci Rep . 2021 May 10;11(1):9819
UCrea Repositorio Abierto de la Universidad de Cantabria
Universidad de Cantabria (UC)
The simplicity and low cost of rapid point-of-care tests greatly facilitate large-scale population testing, which can contribute to controlling the spread of the COVID-19 virus. We evaluated the applicability of a self-testing strategy for SARS-CoV2
Autor:
Aitor Odriozola, Alvaro Santos-Laso, María del Barrio, Joaquín Cabezas, Paula Iruzubieta, María Teresa Arias-Loste, Coral Rivas, Juan Carlos Rodríguez Duque, Ángela Antón, Emilio Fábrega, Javier Crespo
Publikováno v:
International Journal of Molecular Sciences. 24:7791
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide, and its incidence has been increasing in recent years because of the high prevalence of obesity and metabolic syndrome in the Western population. A